Package Leaflet: Information for the User
Quetiapina Sandoz Pharmaceutical50 mg prolonged-release tablets EFG
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Quetiapina Sandoz Farmacéutica contains a substance called quetiapine. It belongs to a group of medicines called antipsychotics. Quetiapine can be used to treat several diseases, such as:
When using quetiapine to treat major depressive episodes in major depressive disorder, it will be taken in addition to another medicine that is being used to treat this disease.
Your doctor may continue prescribing quetiapine, even when you are feeling better.
Do not takeQuetiapina Sandoz Pharmaceutical
If you have any doubts, consult your doctor or pharmacist before taking quetiapine.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quetiapina Sandoz Pharmaceutical if:
Inform your doctor immediately if after taking quetiapine you experience any of the following:
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to be effective, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information obtained from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 years old with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Severe skin reactions (SCARs)
With the use of this medication, very rarely reported severe skin reactions (SCARs) have been noted, which may put your life at risk or be fatal. These typically manifest as:
If you develop these symptoms, stop using Quetiapina Sandoz Pharmaceutical and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should regularly monitor your weight.
Children and adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
Other medications and Quetiapina Sandoz Pharmaceutical
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take quetiapine if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Taking Quetiapina Sandoz Pharmaceutical with food, drinks, and alcohol
Pregnancy and breastfeeding
The following symptoms, which may represent withdrawal syndrome, may appear in newborns of mothers who have used quetiapine in the last trimester (last three months of their pregnancy): tremors, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and feeding difficulties. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
These tablets may make you feel drowsy. Do not drive or operate tools or machinery until you know how the tablets affect you.
Effect on Urine Drug Detection Tests
If you are undergoing a urine drug detection test, taking quetiapine may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when using certain analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Quetiapina Sandoz Pharmaceutical 50 mg contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per prolonged-release tablet; that is, it is essentially "sodium-free".
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and needs, but will usually be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older age
If you are an older person, your doctor may change your dose.
Use in children and adolescents
Quetiapina should not be used in children and adolescents under 18 years of age.
If you take moreQuetiapina Sandoz Pharmaceuticalthan you should
If you take more quetiapina than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats.
If you have taken more quetiapina than you should, consult your doctor or pharmacist immediatelyor call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount used.
If you forget to takeQuetiapina Sandoz Pharmaceutical
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Quetiapina Sandoz Pharmaceutical
If you stop taking quetiapina abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common:may affect more than 1 in 10 people
Common:may affect up to 1 in 10 people
Uncommon:(may affect up to 1 in 100 people)
Rare:may affect up to 1 in 1,000 people
Very rare:may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from available data
This medicine belongs to a class of medicines that can cause serious heart rhythm problems that may be life-threatening in severe cases.
Some side effects are only seen when blood tests are done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreased numbers of certain types of blood cells, decreased red blood cells, increased creatine phosphokinase in the blood (a substance found in muscles), decreased sodium in the blood, and increased prolactin hormone in the blood. Prolactin increases may, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common:may affect more than 1 in 10 people
Common:may affect up to 1 in 10 people
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after CAD/EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
This medication does not requireany special storage temperature.
Medications should not be thrown down the drain or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Quetiapina Sandoz Pharmaceutical
Tablet core: hypromellose, microcrystalline cellulose, anhydrous sodium citrate, and magnesium stearate.
Tablet coating: titanium dioxide (E-171), hypromellose, macrogol 400, polysorbate 80, yellow iron oxide (E-172), red iron oxide (E-172), and black iron oxide (E-172).
Appearance of the product and contents of the packaging
The tablets are brown, oblong, biconvex, and have "Q 50" engraved on one side and are smooth on the other.
They are presented in: aluminum/PVC-PVDC blister, in packs of 60 tablets.
Marketing authorization holderand manufacturer
Marketing authorization holder
Sandoz Pharmaceutical, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Merckle GmbH
Ludwig-Merckle Strasse 3
D-89143 Blaubeuren-Weiler
Germany
Last review date of the leaflet: July 2024
The detailed information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.